ARCOTATUG TAVATECAN
UNII VNF8V7Q4RS

Substance Identification & Data

This profile provides standardized clinical and technical data for Arcotatug Tavatecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VNF8V7Q4RS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3023387-99-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VNF8V7Q4RS

CAS Registry Number

3023387-99-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ARCOTATUG TAVATECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C189808

National Cancer Institute reference terminology for clinical and research data.

INN ID

13668

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Arcotatug Tavatecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ARCOTATUG TAVATECAN

Common Names & Synonyms

ARCOTATUG TAVATECAN [INN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN CLDN18.2) (HUMAN MONOCLONAL HB37A6 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HB37A6 .KAPPA.-CHAIN, DIMER, 302,302'-BIS(N-(2-(ACETYLAMINO)-4-O-(2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALACTOPYRANOSYL)-2-DEOXY-6-O-R-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINE), WHERE R = (H OR 6-DEOXY-.ALPHA.-L-GALACTOPYRANOSYL), CLICK REACTION PRODUCT WITH 1,1'-(((((13-(1.ALPHA.,8.ALPHA.,9.BETA.)-BICYCLO(6.1.0)NON-4-YN-9-YL-1,11-DIOXO-9,9-DIOXIDO-2,5,12-TRIOXA-9-THIA-8,10-DIAZATRIDEC-1-YL)AMINO)SULFONYL)IMINO)BIS(2,1-ETHANEDIYLOXYCARBONYL))BIS(L-VALYL-N-(4-((((((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-ALANINAMIDE)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED TO THE THE CAMPTOTHECIN DERIVATIVE EXATECAN VIA A LINKER (ARCOTATUG TAVATECAN)

External Clinical & Regulatory Resources

Previous UNIIVNF68WB68W

Next UNIIVNG3VK6NV4